Medical Technologies Evaluation Programme

Content under review

We're updating this page following the publication of our new methods, processes and topic selection manuals. Our previous manuals still apply to evaluations that started before 1 February 2022. The new manuals apply to evaluations that began after this date.

Anyone can ask us to consider a device, diagnostic or digital technology for NICE guidance or advice.

Our Medical Technologies Evaluation Programme (MTEP) considers technologies that could offer benefits to patients and the health and social care system over current practice.

Notify a product to NICE

Manufacturers, distributors and agents

Add your technology to HealthTech Connect, where you can access information and support. Got a question? Contact us.

Health and social care staff, patients and the public

Email us at with the name and potential benefits of the technology.

Notification and selection process timeline

Our product went from being in 4 hospitals to 15 within 6 months of guidance publication. That was incredible.

How we select technologies

A technology is likely to be selected if it meets the eligibility criteria and:

  • it offers substantial benefits to patients or the health and care system compared with current practice
  • the benefits are plausible, clearly described, easily understood and supported by evidence
  • developing guidance would mean faster and more consistent adoption of the technology.

You can view products considered for selection (Word).

Eligibility criteria

  1. The technology must be suitable for development under one of our guidance programmes, and not currently in development.
  2. It must be a new technology, or an innovative modification of an existing technology, which will have benefits to the patient or the NHS when judged against comparators.
  3. The technology must have one of the following CE marks (or equivalent regulatory approval) or be expected to get one within 12 months:
    • a medical device (under EC directive 2007/47/EC or 93/42/EEC)
    • an active medical device (under EC directive 90/385/EEC)
    • an active implantable medical device (under EC directive 90/385/EEC)
    • an in vitro diagnostic medical device (under EC directive 98/79/EC).
    The technology must also be available to the NHS, or have plans to be launched in the NHS.

The CE mark is a mandatory conformity mark for all products placed on the single market in the European Economic Area, including medical devices. The mark certifies that a product has met EU consumer safety, health or environmental requirements.

You can also download the eligibility criteria as a PDF.

Types of guidance and advice

Notified medical technologies are usually developed as one of the following:

Market access support

Our Office for Market Access offers bespoke services to pharmaceutical, medtech and diagnostics companies.

We can:

  • help you identify the most appropriate journey for your product through NICE
  • provide support regarding our processes and methods
  • offer engagement opportunities in relation to particular products, and as part of the Early Access to Medicines Scheme (PDF)
  • arrange safe harbour meetings between companies, NICE and other relevant parties in the NHS landscape.

Contact us

We're happy to answer any questions or to arrange a meeting to discuss things in more detail. You can email us at